Opioid Use Disorder and Sublocade® Treatment

Request an Appointment
+1 281-554-0123

Opioid Use Disorder and Sublocade® Treatment

What Is Opioid Use Disorder?

Opioid Use Disorder (OUD) is a medical condition characterized by the recurrent use of opioids despite harmful consequences, including physical, psychological, social, and occupational problems. Individuals with OUD may develop a dependence on prescription pain medications or illicit opioids, such as heroin, leading to cravings, withdrawal symptoms, and difficulty controlling use.

OUD is considered a chronic, relapsing brain disorder, and it can significantly impact a person’s quality of life if not properly treated. Evidence-based treatments, including medication-assisted treatment (MAT), counseling, and behavioral therapies, are essential components of recovery.

Common Risk Factors for Opioid Use Disorder

OUD can develop from a combination of genetic, environmental, and behavioral factors. Common risk factors include:

  • Long-term use of prescription opioids for pain management

  • History of substance use disorders in the individual or family

  • Co-occurring mental health conditions such as anxiety, depression, or PTSD

  • Trauma or exposure to high-stress environments

  • Social or peer pressure influencing drug use

  • Early exposure to addictive substances

Understanding these risk factors can help identify individuals who may benefit from early intervention or preventive strategies.

Symptoms of Opioid Dependence

Signs of opioid dependence may include:

  • Strong cravings for opioids

  • Inability to reduce or stop use despite negative consequences

  • Withdrawal symptoms such as nausea, sweating, anxiety, or irritability when not using

  • Neglecting responsibilities at work, school, or home

  • Social withdrawal or isolation

  • Continued use despite health problems

These symptoms often interfere with daily life and relationships, highlighting the need for professional treatment.

Onset and Duration

Opioid dependence can develop within days to weeks of regular opioid use, depending on the potency, dosage, and individual susceptibility. Left untreated, OUD can become a long-term chronic condition with cycles of relapse and recovery.

Early recognition and intervention are critical to prevent complications, reduce risk of overdose, and improve long-term recovery outcomes.

Understanding Sublocade® Treatment for Opioid Dependence

Sublocade® is a long-acting, FDA-approved injectable form of buprenorphine used as part of medication-assisted treatment (MAT) for adults with moderate to severe opioid use disorder. It is designed to reduce cravings and withdrawal symptoms while supporting recovery and long-term abstinence from opioids.

How Sublocade® Works

  • Sublocade® delivers a once-monthly, subcutaneous injection of buprenorphine

  • It works by partially activating opioid receptors, reducing cravings and minimizing withdrawal symptoms

  • Because it is administered monthly, it reduces the risk of missed doses and medication diversion

  • It is used as part of a comprehensive treatment plan, including counseling and behavioral support

Benefits of Sublocade®

  • Reduces cravings and withdrawal symptoms

  • Supports long-term adherence to treatment

  • Minimizes daily dosing and medication management challenges

  • Can be used as part of an integrated recovery program with therapy and support services

Safety and Considerations

Sublocade® is generally safe when administered by trained medical professionals. Common side effects may include:

  • Injection site reactions (pain, redness, swelling)

  • Headache or fatigue

  • Nausea or constipation

Sublocade® is not suitable for everyone, including individuals with:

  • Severe liver impairment

  • Known hypersensitivity to buprenorphine

  • Current opioid use without proper induction

A full medical evaluation is required to determine eligibility and ensure safe treatment.

Recovery and Ongoing Support

Medication-assisted treatment with Sublocade® is most effective when combined with counseling, behavioral therapy, and support programs. Regular follow-up visits help:

  • Monitor response to treatment

  • Adjust dosages if needed

  • Address co-occurring mental health conditions

  • Provide education and support for relapse prevention

With consistent treatment, individuals can experience reduced cravings, improved functioning, and long-term recovery success.

  • Suboxone is an FDA-approved medication used in medication-assisted treatment (MAT) to reduce opioid cravings and withdrawal symptoms. It contains a combination of buprenorphine and naloxone and is taken as a daily sublingual film or tablet. At Family Psychiatry, Suboxone is prescribed as part of a comprehensive treatment plan that includes ongoing psychiatric monitoring and follow-up care.

  • Sublocade is an FDA-approved once-monthly extended-release buprenorphine injection administered by a healthcare provider. Unlike daily oral medications, Sublocade delivers a consistent level of buprenorphine throughout the month, eliminating the need for daily dosing and reducing the risk of missed doses or misuse. It is an effective option for patients who are already stabilized on oral buprenorphine therapy.

  • Patients who have been stabilized on a consistent dose of oral buprenorphine or Suboxone may be good candidates for Sublocade under medical supervision. Dr. Saeed at Family Psychiatry evaluates each patient's treatment history, stability, and overall health before recommending the transition to Sublocade to ensure it is the safest and most effective next step in their recovery.

  • No. Sublocade and other medications for opioid use disorder are most effective when combined with counseling and behavioral support as part of a comprehensive treatment plan. At Family Psychiatry, medication management is provided alongside referrals to counseling and community support resources to address the full scope of recovery and reduce the risk of relapse.

  • Treatment duration for opioid use disorder varies significantly depending on each patient's recovery progress, history of use, and overall health. Research consistently shows that longer duration of treatment leads to better long-term outcomes. Family Psychiatry provides ongoing follow-up care and medication management for as long as it is clinically appropriate to support sustained recovery.

  • Family Psychiatry in League City, TX provides medication-assisted treatment for opioid use disorder including Suboxone and Sublocade therapy. Dr. Mohammad Saeed serves patients from Clear Lake, Friendswood, Dickinson, Kemah, Galveston, and the greater Houston area. Call 281-554-0123 to schedule a confidential evaluation.